TMEM219 signaling promotes intestinal stem cell death and exacerbates colitis

Area of Science:

• Gastroenterology
• Cell Biology
• Immunology

Background:

• Inflammatory bowel disease (IBD) pathogenesis involves impaired mucosal regeneration.
• Intestinal stem cell (ISC) dysfunction is increasingly implicated in IBD.
• Mechanisms of abrogated mucosal repair in Crohn's disease (CD) require further elucidation.

Purpose of the Study:

• Investigate the role of Transmembrane protein 219 (TMEM219) in ISC death and mucosal repair in CD.
• Determine if TMEM219 blockade can restore regenerative capacity and ameliorate colitis.

Main Methods:

• Analysis of TMEM219 expression in CD patients.
• Mechanistic studies identifying TMEM219-mediated proapoptotic pathways involving Caspase-8.
• In vitro minigut self-renewal assays.
• In vivo studies using DSS-induced and T cell-mediated colitis models.
• Pharmacological blockade with ecto-TMEM219.
• Genetic deletion of TMEM219 in ISCs (TMEM219fl/flLGR5cre mice).

Main Results:

• Elevated TMEM219 expression in CD patients, correlating with disease activity and treatment non-response.
• TMEM219 signaling activates a proapoptotic cascade leading to ISC death.
• Pharmacological TMEM219 blockade restored ISC self-renewal in vitro and ameliorated colitis in vivo.
• Genetic TMEM219 deletion in ISCs rescued mucosal regeneration in vitro and in vivo.

Conclusions:

• TMEM219-dependent ISC death is a key mechanism exacerbating colitis in CD.
• TMEM219 blockade represents a potential therapeutic strategy to restore intestinal self-renewal and promote mucosal healing in IBD.